Based in Ohio, NAMSA is the only full continuum Contract Research Organization in the world focused exclusively on medical devices.
NAMSA was the first independent company world wide to focus solely on testing medical device materials for safety.
NAMSA’s suite of services are designed to lower development costs and accelerate regulatory approval and commercialization globally for medical device and in vitro diagnostics (IVD) technologies.
NAMSA offers expert medical device testing, regulatory, reimbursement and quality consulting services, and clinical research support to aid clients at every stage in the medical device development continuum.
INVESTMENT DATE
2020
SECTOR
Medtech
TRANSACTION TYPE
Buy-Out
GROWTH THEME
Product Development / Internationalization
LOCATION
United States